Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploiting Long Non-Coding RNAs and Circular RNAs as Pharmacological Targets in Triple-Negative Breast Cancer Treatment. | Cancers (Basel) | 2023 | 37627209 | PubTator, text mining | PubMed |
| Structural and functional insights into the modulation of T cell costimulation by monkeypox virus protein M2. | Nat Commun | 2023 | 37626059 | PubTator, text mining | PubMed |
| Comprehensive characterization of pyroptosis phenotypes with distinct tumor immune profiles in gastric cancer to aid immunotherapy. | Aging (Albany NY) | 2023 | 37595258 | PubTator, text mining | PubMed |
| Integrated single cell and bulk sequencing analysis identifies tumor reactive CXCR6+ CD8 T cells as a predictor of immune infiltration and immunotherapy outcomes in hepatocellular carcinoma. | Front Oncol | 2023 | 37593098 | PubTator, text mining | PubMed |
| A novel hepatocellular carcinoma-specific mTORC1-related signature for anticipating prognosis and immunotherapy. | Aging (Albany NY) | 2023 | 37589508 | PubTator, text mining | PubMed |
| Hepatocellular carcinoma cell differentiation trajectory predicts immunotherapy, potential therapeutic drugs, and prognosis of patients. | Open Life Sci | 2023 | 37589009 | PubTator, text mining | PubMed |
| CLDN18.2 expression and its impact on prognosis and the immune microenvironment in gastric cancer. | BMC Gastroenterol | 2023 | 37582713 | PubTator, text mining | PubMed |
| Establishment of a prognostic model toward lung squamous cell carcinoma based on m7G-related genes in the cancer genome atlas. | Physiol Genomics | 2023 | 37575065 | PubTator, text mining | PubMed |
| Dynamic thresholding and tissue dissociation optimization for CITE-seq identifies differential surface protein abundance in metastatic melanoma. | Commun Biol | 2023 | 37563418 | PubTator, text mining | PubMed |
| Theoretical and semi-analytical simulation for a two-predator-one-prey model during the mating period. | PLoS One | 2023 | 37556454 | PubTator, text mining | PubMed |
| The novel role of LDHA/LDHB in the prognostic value and tumor-immune infiltration in clear cell renal cell carcinoma. | PeerJ | 2023 | 37547725 | PubTator, text mining | PubMed |
| Progress of PD-1/PD-L1 signaling in immune response to liver transplantation for hepatocellular carcinoma. | Front Immunol | 2023 | 37545535 | PubTator, text mining | PubMed |
| M1/M2 macrophages and their overlaps - myth or reality? | Clin Sci (Lond) | 2023 | 37530555 | PubTator, text mining | PubMed |
| Disulfidptosis-associated LncRNAs index predicts prognosis and chemotherapy drugs sensitivity in cervical cancer. | Sci Rep | 2023 | 37528124 | PubTator, text mining | PubMed |
| Cuproptosis/ferroptosis-related gene signature is correlated with immune infiltration and predict the prognosis for patients with breast cancer. | Front Pharmacol | 2023 | 37521466 | PubTator, text mining | PubMed |
| Astragaloside IV Regulates cGAS-STING Signaling Pathway to Alleviate Immunosuppression Caused by PRRSV Infection. | Viruses | 2023 | 37515271 | PubTator, text mining | PubMed |
| Bridging Pyroptosis and Immunity: A Comprehensive Study of the Pyroptosis-Related Long Non-Coding RNA Signature in Breast Cancer. | Life (Basel) | 2023 | 37511974 | PubTator, text mining | PubMed |
| Upper Tract Urothelial Carcinoma: A Rare Malignancy with Distinct Immuno-Genomic Features in the Era of Precision-Based Therapies. | Biomedicines | 2023 | 37509415 | PubTator, text mining | PubMed |
| Comprehensive analysis of m6A regulators associated with immune infiltration in Hepatitis B virus-related hepatocellular carcinoma. | BMC Gastroenterol | 2023 | 37507670 | PubTator, text mining | PubMed |
| Antibody-Drug Conjugates in Breast Cancer: Ascent to Destiny and Beyond-A 2023 Review. | Curr Oncol | 2023 | 37504334 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=17